Signaling pathways | ROS targets | Effects | Related diseases | References |
---|---|---|---|---|
The NLRP3 inflammasome signaling pathway | TRX; mtDNA; Ca2 + influx | Production of IL-1β and IL-18; initiation of pyroptosis | Diabetic nephropathy; TRAPS; osteoarthritis; Alzheimer’s disease | |
NF-κB signaling pathway | IκBα; IKKβ; NIK | M1 macrophage transcription; induction of TNF-α, IL-1β, IL-6, IL-12 and COX-2 gene expression; differentiation of Th1, Th17, and Tfh cells | Inflammatory bowel disease; arthritis; sepsis; gastritis; asthma; atherosclerosis | |
MAPKs signaling pathway | ASK1; mixed lineage kinase 3; growth factor receptors | M1 macrophage transcription; production of TNF-α, IL-1β, IL-8 and IL-10; decrease in IL-12 and IFN-β production | Asthma; TRAPS; COPD | |
JAK/STAT signaling pathway | Activation of STAT by DNA methylation | Production of chemokines; differentiation and apoptosis of hematopoietic cells | Rheumatoid arthritis; psoriasis; inflammatory bowel disease | |
Nrf2 signaling pathway | Keap1; MAPKs; PI3K; NF-κB | Activation of heme oxygenase-1, NADPH dehydrogenase, SOD, and CAT | Acute lung injury; nephritis; osteoarthritis; inflammatory bowel disease | |
PI3K/AKT signaling pathway | Activation of PI3K; phosphorylation of AKT; inactivation of phosphatase and tensin homology | Expression and activation of inflammatory mediators; recruitment of inflammatory cells; airway remodeling; corticosteroid insensitivity | Chronic inflammatory respiratory diseases |